The healthcare company has posted a loss in the wake of a failed stock offer.
The Public Investment Corporation, South Africa’s biggest stock investor, says local ownership is key for growing the economy and empowering people.
The gloves came off this week as two companies and a dominant shareholder battled it out for control of the pharmaceutical company Adcock Ingram.
The drawn-out battle for Adcock now sees CFR’s offer for Adcock now facing resistance from the PIC, which says the offer is not up to scratch.
A day after putting in an offer to acquire part of Adcock Ingram, Bidvest is taking the company to court over an "unlawful" guarantee.
Drugmaker Adcock Ingram says the $1.2-billion takeover bid from CFR Pharmaceuticals is still the best option, despite Bidvest’s offer.
A Chilean group’s $1.2-billion bid for Adcock Ingram has been challenged by a court action from Bidvest.
Bidvest has put in a R4-billion offer for pharmaceuticals company Adcock, countering that of Chilean company CFR Pharmaceuticals.
Rising import costs led to decreased profits and margins at Adcock, which has suspended its dividend while takeover talks with CFR continue.
The pharmaceutical company Adcock’s biggest shareholder PIC says it has not yet made a decision about whether to support the takeover of CFR.
Chile’s largest drugmaker will decide within weeks whether to make a binding offer for Adcock Ingram Holdings.
Adcock Ingram has entered into discussions with a Chile-based firm, which could see SA benefit from a possible combined revenue of R12.1-billion.
The pharmaceuticals giant has reported its’ profit fell 5.4% as it continues takeover talks that may lead to the company being bought.
Adcock Ingram, SA’s largest supplier of hospital products, may gain a further 12% from a 30-month high after it got takeover offers.
A tale of two companies — one saw generics as the future, the other is playing catch-up.
Adcock Ingram’s battle with the MCC over Synap Forte and similar drugs has cast doubt on the state attorney’s capacity to handle legal challenges.
The Medicines Control Council has obtained an urgent court order to stop the continued sale of potentially deadly medicines.
SA’s second-biggest drug maker expects full-year profit to fall due to BEE once-off charge.
Adcock Ingram posted a 16,1% rise in full-year profit bolstered by volumes growth and price increases and said it expected further volume growth.
Adcock Ingram posted a 4,6% rise in full-year headline earnings per share on Tuesday, and said its core businesses had remained resilient.
